51 related articles for article (PubMed ID: 20191895)
1. [Prognostic significance of leukemia-associated phenotype in correlation with other biologic markers in acute myeloid leukemia patients].
Dăscălescu A; Zlei M; Grigore G; Dănăila C; Jitaru D; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1176-81. PubMed ID: 20191895
[TBL] [Abstract][Full Text] [Related]
2. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of CXCR4 and FAK expression in acute myelogenous leukemia.
Tavernier-Tardy E; Cornillon J; Campos L; Flandrin P; Duval A; Nadal N; Guyotat D
Leuk Res; 2009 Jun; 33(6):764-8. PubMed ID: 19042019
[TBL] [Abstract][Full Text] [Related]
4. Expression of poliovirus receptor-related proteins PRR1 and PRR2 in acute myeloid leukemia: first report of surface marker analysis, contribution to diagnosis, prognosis and implications for future therapeutical strategies.
Graf M; Reif S; Hecht K; Kroell T; Nuessler V; Schmetzer H
Eur J Haematol; 2005 Dec; 75(6):477-84. PubMed ID: 16313259
[TBL] [Abstract][Full Text] [Related]
5. Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia.
Tamura H; Dan K; Tamada K; Nakamura K; Shioi Y; Hyodo H; Wang SD; Dong H; Chen L; Ogata K
Clin Cancer Res; 2005 Aug; 11(16):5708-17. PubMed ID: 16115907
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Fas (CD95) and TRAIL receptors (DR4/DR5) expression in acute myelogenous leukemia.
Min YJ; Lee JH; Choi SJ; Chi HS; Lee JS; Kim WK; Lee KH
Leuk Res; 2004 Apr; 28(4):359-65. PubMed ID: 15109535
[TBL] [Abstract][Full Text] [Related]
7. [Immunophenotypic study of acute myeloid leukemia (AML): biological significance and prognostic implications].
Rigolin GM; Latorraca A; Moretti S; Previati R; Lanza F
Boll Soc Ital Biol Sper; 1993 May; 69(5):301-5. PubMed ID: 8129911
[TBL] [Abstract][Full Text] [Related]
8. Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells.
Kalinkovich A; Tavor S; Avigdor A; Kahn J; Brill A; Petit I; Goichberg P; Tesio M; Netzer N; Naparstek E; Hardan I; Nagler A; Resnick I; Tsimanis A; Lapidot T
Cancer Res; 2006 Nov; 66(22):11013-20. PubMed ID: 17108140
[TBL] [Abstract][Full Text] [Related]
9. Over-expression of tumor necrosis factor-alpha in bone marrow biopsies from patients with myelodysplastic syndromes: relationship to anemia and prognosis.
Stifter G; Heiss S; Gastl G; Tzankov A; Stauder R
Eur J Haematol; 2005 Dec; 75(6):485-91. PubMed ID: 16313260
[TBL] [Abstract][Full Text] [Related]
10. Expression of MAC-1 (CD11b) in acute myeloid leukemia (AML) is associated with an unfavorable prognosis.
Graf M; Reif S; Kröll T; Hecht K; Nuessler V; Schmetzer H
Am J Hematol; 2006 Apr; 81(4):227-35. PubMed ID: 16550517
[TBL] [Abstract][Full Text] [Related]
11. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
[TBL] [Abstract][Full Text] [Related]
13. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype.
Konoplev S; Rassidakis GZ; Estey E; Kantarjian H; Liakou CI; Huang X; Xiao L; Andreeff M; Konopleva M; Medeiros LJ
Cancer; 2007 Mar; 109(6):1152-6. PubMed ID: 17315232
[TBL] [Abstract][Full Text] [Related]
15. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
Al-Mawali A; Gillis D; Hissaria P; Lewis I
Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of beta-catenin and topoisomerase IIalpha in de novo acute myeloid leukemia.
Chen CC; Gau JP; You JY; Lee KD; Yu YB; Lu CH; Lin JT; Lan C; Lo WH; Liu JM; Yang CF
Am J Hematol; 2009 Feb; 84(2):87-92. PubMed ID: 19127593
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival.
Vande Broek I; Leleu X; Schots R; Facon T; Vanderkerken K; Van Camp B; Van Riet I
Haematologica; 2006 Feb; 91(2):200-6. PubMed ID: 16461304
[TBL] [Abstract][Full Text] [Related]
18. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
Yang DH; Lee JJ; Mun YC; Shin HJ; Kim YK; Cho SH; Chung IJ; Seong CM; Kim HJ
Am J Hematol; 2007 Jan; 82(1):1-5. PubMed ID: 16986129
[TBL] [Abstract][Full Text] [Related]
19. Leukemic cluster growth in culture is an independent risk factor for acute myeloid leukemia and short survival in patients with myelodysplastic syndrome.
Bernimoulin M; Stern M; Tichelli A; Jotterand M; Gratwohl A; Nissen C
Acta Haematol; 2008; 119(4):226-35. PubMed ID: 18566541
[TBL] [Abstract][Full Text] [Related]
20. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]